Goldman Sachs’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-790,053
| Closed | -$47.3M | – | 4667 |
|
|
2019
Q4 | $47.3M | Buy |
790,053
+326,201
| +70% | +$19.5M | 0.01% | 1059 |
|
|
2019
Q3 | $13M | Buy |
463,852
+126,156
| +37% | +$3.54M | ﹤0.01% | 1796 |
|
|
2019
Q2 | $12.8M | Buy |
337,696
+80,561
| +31% | +$3.05M | ﹤0.01% | 1839 |
|
|
2019
Q1 | $10M | Buy |
257,135
+106,578
| +71% | +$4.16M | ﹤0.01% | 2019 |
|
|
2018
Q4 | $3.21M | Sell |
150,557
-46,213
| -23% | -$985K | ﹤0.01% | 2587 |
|
|
2018
Q3 | $7.79M | Buy |
196,770
+21,328
| +12% | +$844K | ﹤0.01% | 2180 |
|
|
2018
Q2 | $6.7M | Buy |
175,442
+133,213
| +315% | +$5.09M | ﹤0.01% | 2247 |
|
|
2018
Q1 | $1.27M | Sell |
42,229
-37,868
| -47% | -$1.14M | ﹤0.01% | 3089 |
|
|
2017
Q4 | $2.5M | Buy |
80,097
+65,092
| +434% | +$2.03M | ﹤0.01% | 2709 |
|
|
2017
Q3 | $420K | Buy |
15,005
+86
| +0.6% | +$2.41K | ﹤0.01% | 3581 |
|
|
2017
Q2 | $285K | Sell |
14,919
-3,472
| -19% | -$66.3K | ﹤0.01% | 3821 |
|
|
2017
Q1 | $313K | Sell |
18,391
-312
| -2% | -$5.31K | ﹤0.01% | 3760 |
|
|
2016
Q4 | $342K | Buy |
18,703
+6,099
| +48% | +$112K | ﹤0.01% | 3647 |
|
|
2016
Q3 | $224K | Buy |
+12,604
| New | +$224K | ﹤0.01% | 3862 |
|